A detailed history of Elmwood Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Elmwood Wealth Management, Inc. holds 2,185 shares of ABBV stock, worth $386,635. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,185
Previous 2,285 4.38%
Holding current value
$386,635
Previous $391,000 10.23%
% of portfolio
0.19%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$163.84 - $199.33 $16,384 - $19,933
-100 Reduced 4.38%
2,185 $431,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $51,142 - $58,272
320 Added 16.28%
2,285 $416,000
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $49,811 - $56,099
-362 Reduced 15.56%
1,965 $304,000
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $3,339 - $3,866
25 Added 1.09%
2,327 $346,000
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $2,650 - $3,298
-20 Reduced 0.86%
2,302 $310,000
Q1 2023

Apr 28, 2023

BUY
$144.61 - $166.54 $19,811 - $22,815
137 Added 6.27%
2,322 $370,000
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $26,857 - $33,982
250 Added 12.92%
2,185 $296,000
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $28,950 - $31,871
-283 Reduced 12.76%
1,935 $209,000
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $9,391 - $12,567
-128 Reduced 5.46%
2,218 $218,000
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $151,317 - $229,415
2,346 New
2,346 $178,000
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $169,216 - $211,726
-2,346 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $215,855 - $289,050
2,346 New
2,346 $222 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Elmwood Wealth Management, Inc. Portfolio

Follow Elmwood Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.